皓元医药

688131 SSE 证监会行业分类 M73研究和试验发展

Key Metrics

Market Cap

13.9B ($2.0B)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

2.3B

Net Income

198.0M

Gross Margin

N/A

Op. Margin

10.4%

Net Margin

8.7%

ROE

6.8%

ROA

3.6%

D/E

0.90

Dividend Yield

N/A

EPS

0.96

Current Ratio

2.52

Price History

Company Info

Industry	M73研究和试验发展
Market Segment	STAR Market
Currency	CNY
Fiscal Year	2024

Business Overview

Shanghai Haoyuan Chemexpress Co., Ltd. researches, develops, and manufactures pharmaceutical intermediates and small molecule drugs. The company offers APIs and API intermediates, vitamin D series compounds, CRO building blocks, and CRO life bioscience compounds. The company was founded in 2006 and is headquartered in Shanghai, China.

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 皓元医药

Ticker	688131
Exchange	SSE
Sector	证监会行业分类
Industry	M73研究和试验发展